Cat. No. Name Size Price Add Cart
KI0211R4062 mg$192
R4065 mg$299.2
R40610 mg$475.2
R40650 mg$1531.2
R406200 mg$4347.2

Chemical Characteristic

Product NameR406
CAS No.841290-81-1
Molecular Weight 628.63
FormulaC28H29FN6O8S
Chemical Name6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one benzenesulfonate
SmilesO1c2c(NC(=O)C1(C)C)nc(cc2)Nc1nc(ncc1F)Nc1cc(c(c(c1)OC)OC)OC c1(ccccc1)S(=O)(=O)O
Chemical Structure

Biological activities

R406 is an ATP-competitive inhibitor of spleen tyrosine kinase (Syk) kinase with an IC50 of 41 nM. R406 inhibits ATP binding with a Ki of 30 nM. R406 inhibits all other kinases tested at 5- to 100-fold less potency than Syk by phosphorylation of target proteins. After Syk, Flt3 autophosphorylation is most potently inhibited by R406 at approximately 5-fold less potency than Syk activity. R406 is potent inhibitor of immunoglobulin E (IgE) - and IgG-mediated activation of Fc receptor signaling with an EC50 of 56 nM. R406 exhibits antagonistic activity with an IC50 estimated to be 93 nM. [1] R406 inhibits phosphorylation of Syk substrate linker for activation of T cells in mast cells and B-cell linker protein/SLP65 in B cells. Furthermore, R406 blocks Syk-dependent FcR-mediated activation of monocytes/ macrophages and neutrophils and BCR-mediated activation of B lymphocytes. [1] R406 inhibits BCR-derived prosurvival signals. R406 induces CLL cell apoptosis in NLC cocultures. R406 blocks CCL3 and CCL4 secretion by CLL cells in response to BCR triggering and blocks BCR downstream signaling in CLL cells. R406 also blocks the intracellular calcium flux after anti-IgM stimulation. Treatment with R406 effectively blocks calcium mobilization in response to BCR stimulation. R406 inhibits proliferation of Syk-transformed pre-B cells, and induces apoptosis in non-Hodgkin lymphoma (NHL) and CLL cells. R406 abrogates the BCR-dependent up-regulation of important adhesion and costimulatory molecules, such as CD54, CD62L, CD44, CD40, CD80, and CD86. [2] In mice, administration of R406 reduces vascular leakage and edema in the Arthus reaction elicited by immune complexes. R406 also shows efficacy in inhibiting paw inflammation in two antibody-induced arthritis mouse models. [1]

Protocols

A 10 mM stock solution of R406, stored in aliquots at -80°C, is diluted in DMSO. [1]

References

[1] Braselmann S, et al. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. J Pharmacol Exp Ther. 2006, 319(3): 998-1008.
[2] Quiroga MP, et al. B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. Blood. 2009, 114(5): 1029-1037.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.